Seegene, Inc. (096530.KQ)
KRW 23550.0
(-1.26%)
KRW 23550.0
(-1.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 141.76 Billion KRW | -10.94% |
| 2022 | 159.18 Billion KRW | 0.07% |
| 2021 | 159.06 Billion KRW | 54.37% |
| 2020 | 103.04 Billion KRW | 582.79% |
| 2019 | 15.09 Billion KRW | 47.42% |
| 2018 | 10.23 Billion KRW | -48.29% |
| 2017 | 19.79 Billion KRW | -60.31% |
| 2016 | 49.87 Billion KRW | -3.55% |
| 2015 | 51.71 Billion KRW | 68.47% |
| 2014 | 30.69 Billion KRW | -5.79% |
| 2013 | 32.58 Billion KRW | 0.0% |
| 2012 | - KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 153.79 Billion KRW | 3.41% |
| 2024 Q1 | 148.72 Billion KRW | 4.91% |
| 2023 Q2 | 147.55 Billion KRW | -3.04% |
| 2023 Q4 | 141.76 Billion KRW | -1.15% |
| 2023 FY | 141.76 Billion KRW | -10.94% |
| 2023 Q1 | 152.18 Billion KRW | -4.4% |
| 2023 Q3 | 143.41 Billion KRW | -2.8% |
| 2022 Q4 | 159.18 Billion KRW | 2.65% |
| 2022 Q3 | 155.07 Billion KRW | -3.18% |
| 2022 Q2 | 160.15 Billion KRW | -1.41% |
| 2022 Q1 | 162.45 Billion KRW | 2.13% |
| 2022 FY | 159.18 Billion KRW | 0.07% |
| 2021 Q1 | 106.56 Billion KRW | 10.43% |
| 2021 Q4 | 159.06 Billion KRW | 42.47% |
| 2021 Q3 | 111.65 Billion KRW | -0.63% |
| 2021 FY | 159.06 Billion KRW | 54.37% |
| 2021 Q2 | 112.36 Billion KRW | 5.44% |
| 2020 Q3 | 92.55 Billion KRW | 445.88% |
| 2020 FY | 103.04 Billion KRW | 582.79% |
| 2020 Q1 | 16.49 Billion KRW | 30.08% |
| 2020 Q2 | 16.95 Billion KRW | 2.77% |
| 2020 Q4 | 96.49 Billion KRW | 4.26% |
| 2019 Q1 | 10.63 Billion KRW | 3.83% |
| 2019 FY | 15.09 Billion KRW | 47.42% |
| 2019 Q3 | 9.23 Billion KRW | -22.88% |
| 2019 Q2 | 11.97 Billion KRW | 12.67% |
| 2019 Q4 | 12.68 Billion KRW | 37.33% |
| 2018 Q3 | 8.18 Billion KRW | 1.01% |
| 2018 Q2 | 8.1 Billion KRW | -5.67% |
| 2018 Q1 | 8.59 Billion KRW | -56.59% |
| 2018 FY | 10.23 Billion KRW | -48.29% |
| 2018 Q4 | 10.23 Billion KRW | 25.02% |
| 2017 Q4 | 19.79 Billion KRW | -19.84% |
| 2017 Q2 | 50.8 Billion KRW | 0.8% |
| 2017 FY | 19.79 Billion KRW | -60.31% |
| 2017 Q1 | 50.4 Billion KRW | 1.05% |
| 2017 Q3 | 24.69 Billion KRW | -51.38% |
| 2016 FY | 49.87 Billion KRW | -3.55% |
| 2016 Q3 | 48.26 Billion KRW | 0.81% |
| 2016 Q1 | 46.63 Billion KRW | 1.71% |
| 2016 Q2 | 47.87 Billion KRW | 2.66% |
| 2016 Q4 | 49.87 Billion KRW | 3.34% |
| 2015 Q2 | 22.26 Billion KRW | -38.72% |
| 2015 FY | 51.71 Billion KRW | 68.47% |
| 2015 Q4 | 45.85 Billion KRW | 1.44% |
| 2015 Q3 | 45.2 Billion KRW | 102.98% |
| 2015 Q1 | 36.34 Billion KRW | 18.38% |
| 2014 Q4 | 30.69 Billion KRW | -11.85% |
| 2014 Q3 | 34.82 Billion KRW | 0.3% |
| 2014 Q2 | 34.71 Billion KRW | 8.97% |
| 2014 Q1 | 31.85 Billion KRW | -2.23% |
| 2014 FY | 30.69 Billion KRW | -5.79% |
| 2013 FY | 32.58 Billion KRW | 0.0% |
| 2013 Q3 | 26.74 Billion KRW | -2.77% |
| 2013 Q4 | 32.58 Billion KRW | 21.82% |
| 2013 Q1 | 33.73 Billion KRW | 0.0% |
| 2013 Q2 | 27.5 Billion KRW | -18.44% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | - KRW | 0.0% |
| 2012 Q3 | - KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 697.79 Million KRW | -20215.972% |
| InBody Co.,Ltd | 6.08 Billion KRW | -2231.53% |
| Curexo Inc. | 2.05 Billion KRW | -6783.863% |
| i-SENS, Inc. | 143.79 Billion KRW | 1.41% |
| Ray Co., Ltd. | 86.67 Billion KRW | -63.551% |
| Gencurix Inc. | 17.95 Billion KRW | -689.556% |
| Sugentech Inc. | 15.3 Billion KRW | -826.344% |
| L&C Bio Co., Ltd | 82.13 Billion KRW | -72.6% |